LOS ANGELES — Direct oral anticoagulants (DOACs) in patients with a recent intracerebral hemorrhage (ICH) and atrial fibrillation (AF) may have an overall benefit by reducing ischemic stroke, new ...

Abu Dhabi, UAE — The long-standing debate as to when to start anticoagulation in patients with an acute ischemic stroke and atrial fibrillation (AF) looks as though it’s settled. Results of the ...

Using direct oral anticoagulants as a case study, the authors examined how delayed adoption of novel treatments could impact patient health outcomes and cost. Objective: To examine the relationship ...

(WASHINGTON, June 6, 2024) – Patients with atrial fibrillation (Afib) who took low doses of blood-thinning medications known as direct oral anticoagulants (DOACs) experienced more bleeding episodes ...

Direct oral anticoagulants were associated with lower risks of ischemic stroke or systemic embolism and bleeding compared with warfarin. The study included patients with atrial fibrillation (AF) and ...

Patients with atrial fibrillation (Afib) who took low doses of blood-thinning medications known as direct oral anticoagulants (DOACs) experienced more bleeding episodes during the first three months ...

Numerically fewer primary outcome events seen with early DOAC for all infarct sizes, but differences were not significant. HealthDay News — For individuals with minor, moderate, or major stroke, the ...

DOACs are effective, whether initiated early or late after stroke. (HealthDay News) — For individuals with minor, moderate, or major stroke, the treatment effect of early versus late direct oral ...